Leadiant Biosciences (United States)

Leadiant Biosciences is a specialty pharmaceutical company focused on rare diseases and oncology supportive care. The company develops treatments for ultra-rare metabolic disorders, including cerebrotendinous xanthomatosis (CTX), and provides chemotherapy-related supportive care medications. Leadiant’s rare disease expertise addresses conditions with limited treatment options.